Find information on thousands of medical conditions and prescription drugs.

Wegener's granulomatosis

In medicine (rheumatology), Wegener's granulomatosis is a form of vasculitis that affects the lungs, kidneys and other organs. Due to its end-organ damage, it can be a serious disease that requires long-term immune suppression. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
Panniculitis
Waardenburg syndrome
Wagner's disease
WAGR syndrome
Waldenstrom...
Wallerian degeneration
Warkany syndrome
Warts
Waterhouse-Friderichsen...
Watermelon stomach
Wegener's granulomatosis
Weissenbacher Zweymuller...
Werdnig-Hoffmann disease
Werner's syndrome
Whipple disease
Whooping cough
Willebrand disease
Willebrand disease, acquired
Williams syndrome
Wilms tumor-aniridia...
Wilms' tumor
Wilson's disease
Wiskott-Aldrich syndrome
Wolf-Hirschhorn syndrome
Wolff-Parkinson-White...
Wolfram syndrome
Wolman disease
Wooly hair syndrome
Worster-Drought syndrome
Writer's cramp
X
Y
Z
Medicines

It is part of a larger group of vasculitic syndromes that all feature positivity for ANCAs (antineutrophil cytoplasmic antibodies) and affect small and medium-sized blood vessels. Apart from Wegener's, it includes Churg-Strauss syndrome and microscopic polyangiitis.

Signs and symptoms

Initial signs are protean, and diagnosis can be severely delayed due to the non-specific nature of the symptoms. The rhinitis is generally the first sign in most patients.

  • Upper airway, eye and ear disease:
    • Nose: pain, stuffiness, nosebleeds, rhinitis, crusting, saddle-nose deformity
    • Ears: conductive hearing loss due to Eustachian tube dysfunction, sensorineural hearing loss (unclear mechanism)
    • Eyes: pseudotumours, scleritis, conjunctivitis, uveitis, episcleritis
  • Airways:
    • Trachea: subglottal stenosis
    • Lungs: pulmonary nodules, infiltrates (often interpreted as pneumonia), cavitary lesions, pulmonary haemorrhage causing hemoptysis), and rarely bronchial stenosis.
  • Kidney: rapidly progressive segmental necrotising glomerulonephritis (75%), leading to chronic renal failure
  • Arthritis: Pain or swelling (60%), often initially diagnosed as rheumatoid arthritis
  • Skin: nodules on the elbow, purpura, various others (see cutaneous vasculitis)
  • Nervous system: occasionally sensory neuropathy (10%) and rarely mononeuritis multiplex
  • Heart, gastrointestinal tract, brain other organs: rarely affected.

Diagnosis

Vasculitis such as Wegener's granulomatosis is usually only suspected when a patient has had unexplained symptoms for a longer period of time. Determination of ANCAs can aid in the diagnosis, but positivity is not conclusive, and neither are negative ANCAs enough to reject the diagnosis. Cytoplasmic staining ANCAs that react with proteinase 3 (cANCA) are associated with Wegener's.

If the patient has renal failure or cutaneous vasculitis, these are the most logical organs to obtain a biopsy from. Rarely, thoracoscopic lung biopsy is required. On histopathological examination, a biopsy will show leukocytoclastic vasculitis with necrotic changes and granulomatous inflammation. The latter is the main reason for the appellation of "Wegener's granulomatosis", although it is not an essential feature. Unfortunately, many biopsies can be aspecific and 50% provide too little information for the diagnosis of Wegener's.

Differential diagnosis can be extensive. ANCAs can be positive after the use of certain drugs, and other forms of vasculitis can present with very similar symptoms. The saddle-nose deformity is also seen in cocaine abuse.

Read more at Wikipedia.org


[List your site here Free!]


Etanercept to treat Wegener's granulomatosis - Clinical Trial Review - Brief Article
From Journal of Drugs in Dermatology, 10/1/03

This study is currently recruiting patients.

Sponsored by National Institute of Allergy and Infectious Diseases (NIAID)

The Food and Drug Administration has approved etanercept (also called Enbre(R) or TNFR:Fc) for treating rheumatoid arthritis.

This study will examine the use of etanercept in patients with Wegener's granulomatosis, a type of vasculitis (blood vessel inflammation). This study will evaluate etanercept's safety and effectiveness, and particularly its value in reducing the need for predinisone and preventing disease relapse.

Study ID Numbers: 990040; 99-1-0040 NLM Identifier: NCT00001901

COPYRIGHT 2003 Journal of Drugs in Dermatology
COPYRIGHT 2003 Gale Group

Return to Wegener's granulomatosis
Home Contact Resources Exchange Links ebay